Literature DB >> 21086032

Extracellular brain ammonia levels in association with arterial ammonia, intracranial pressure and the use of albumin dialysis devices in pigs with acute liver failure.

Kerstin Zwirner1, Christian Thiel, Karolin Thiel, Matthias H Morgalla, Alfred Königsrainer, Martin Schenk.   

Abstract

In acute liver failure (ALF) hyperammonemia plays a mayor role in the pathogenesis of hepatic encephalopathy (HE) but does not always correlate with the severity of mental deterioration and intracranial pressure (ICP). The aim of our study was to evaluate the association with extracellular brain ammonia, ICP and the therapeutical impact of two albumin dialysis devices. ALF was induced by complete hepatectomy in 13 pigs. All pigs were monitored and treated under intensive care conditions until death. Arterial blood and cerebral microdialysis samples were collected and ICP data recorded. Additionally in 5 pigs, standard albumin dialysis and in 3 animals an albumin dialysis prototype was initiated as a tool. Arterial ammonia increased straight after hepatectomy, while extracellular brain ammonia remained on a moderate level 10 h post ALF initiation. After 16 h the brain ammonia reached arterial ammonia levels before plateauing at 1,200 microM, though the arterial ammonia continued to rise. The ICP correlated with the brain ammonia levels. No impact of the different dialysis therapies on neither blood nor brain ammonia levels was observed. In ALF the extracellular brain ammonia revealed a delayed increase compared to arterial ammonia. It correlated strongly with the ICP and could serve as a sensitive marker for HE development. Albumin dialysis did not affect blood or brain ammonia levels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21086032     DOI: 10.1007/s11011-010-9222-x

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  30 in total

1.  Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure.

Authors:  L E Schmidt; L B Svendsen; V R Sørensen; B A Hansen; F S Larsen
Journal:  Liver Transpl       Date:  2001-08       Impact factor: 5.799

2.  Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure.

Authors:  P Sorkine; R Ben Abraham; O Szold; P Biderman; A Kidron; H Merchav; S Brill; R Oren
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

3.  A new surgical model for hepatectomy in pigs.

Authors:  K Knubben; C Thiel; M Schenk; A Etspüler; T Schenk; M H Morgalla; A Königsrainer
Journal:  Eur Surg Res       Date:  2007-09-21       Impact factor: 1.745

Review 4.  Neurobiology of ammonia.

Authors:  Vicente Felipo; Roger F Butterworth
Journal:  Prog Neurobiol       Date:  2002-07       Impact factor: 11.685

Review 5.  Molecular adsorbent recirculating system (MARS).

Authors:  H K Tan
Journal:  Ann Acad Med Singapore       Date:  2004-05       Impact factor: 2.473

6.  Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow.

Authors:  Rajiv Jalan; Steven W M Olde Damink; Peter C Hayes; Nicolaas E P Deutz; Alistair Lee
Journal:  J Hepatol       Date:  2004-10       Impact factor: 25.083

Review 7.  Role of artificial liver support in hepatic encephalopathy.

Authors:  V Stadlbauer; G A K Wright; R Jalan
Journal:  Metab Brain Dis       Date:  2008-12-21       Impact factor: 3.584

8.  Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure.

Authors:  Christopher Rose; Lars M Ytrebø; Nathan A Davies; Sambit Sen; Geir I Nedredal; Mireille Belanger; Arthur Revhaug; Rajiv Jalan
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

9.  Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis.

Authors:  Tarek I Hassanein; Flemming Tofteng; Robert S Brown; Brendan McGuire; Patrick Lynch; Ravindra Mehta; Fin S Larsen; Jeff Gornbein; Jan Stange; Andres T Blei
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

10.  L-ornithine phenylacetate attenuates increased arterial and extracellular brain ammonia and prevents intracranial hypertension in pigs with acute liver failure.

Authors:  Lars Marius Ytrebø; Rune Gangsøy Kristiansen; Hanne Maehre; Ole Martin Fuskevåg; Trine Kalstad; Arthur Revhaug; María Jover Cobos; Rajiv Jalan; Christopher F Rose
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

View more
  9 in total

1.  Intracranial Pressure Monitoring Demonstrates that Cerebral Edema Is Not Correlated to Hyperammonemia in a Child with Ornithine Transcarbamylase Deficiency.

Authors:  Julie Chantreuil; Géraldine Favrais; Nadine Fakhri; Marine Tardieu; Nicolas Roullet-Renoleau; Thierry Perez; Nadine Travers; Laurent Barantin; Baptiste Morel; Elie Saliba; François Labarthe
Journal:  JIMD Rep       Date:  2015-10-02

2.  Ammonia-induced brain swelling and neurotoxicity in an organotypic slice model.

Authors:  Adam Back; Kelsey Y Tupper; Tao Bai; Paulpoj Chiranand; Fernando D Goldenberg; Jeffrey I Frank; James R Brorson
Journal:  Neurol Res       Date:  2011-12       Impact factor: 2.448

Review 3.  Hyperammonemia in Hepatic Encephalopathy.

Authors:  A R Jayakumar; Michael D Norenberg
Journal:  J Clin Exp Hepatol       Date:  2018-06-20

4.  An in vivo study of a gold nanocomposite biomaterial for vascular repair.

Authors:  A M Ostdiek; J R Ivey; D A Grant; J Gopaldas; S A Grant
Journal:  Biomaterials       Date:  2015-06-30       Impact factor: 12.479

5.  Bile duct ligation of C57BL/6 mice as a model of hepatic encephalopathy.

Authors:  Inja Cho; Bon-Nyeo Koo; Eun Hee Kam; Su Kyoung Lee; Hanseul Oh; So Yeon Kim
Journal:  Anesth Pain Med (Seoul)       Date:  2020-01-31

Review 6.  Neuromonitoring in Rare Disorders of Metabolism.

Authors:  Carlos Castillo-Pinto; Kuntal Sen; Andrea Gropman
Journal:  Yale J Biol Med       Date:  2021-12-29

7.  Alterations of blood-brain barrier and associated factors in acute liver failure.

Authors:  Wei Cui; Cui-Ming Sun; Pei Liu
Journal:  Gastroenterol Res Pract       Date:  2013-05-26       Impact factor: 2.260

Review 8.  Contributions of microdialysis to new alternative therapeutics for hepatic encephalopathy.

Authors:  Liliana Rivera-Espinosa; Esaú Floriano-Sánchez; José Pedraza-Chaverrí; Elvia Coballase-Urrutia; Aristides Iii Sampieri; Daniel Ortega-Cuellar; Noemí Cárdenas-Rodríguez; Liliana Carmona-Aparicio
Journal:  Int J Mol Sci       Date:  2013-08-05       Impact factor: 5.923

Review 9.  Alterations in Expression and Function of ABC Family Transporters at Blood-Brain Barrier under Liver Failure and Their Clinical Significances.

Authors:  Yilin Fan; Xiaodong Liu
Journal:  Pharmaceutics       Date:  2018-07-23       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.